Christopher A. Eide

10.3k citations
101 papers · 4.1k · 2 hit papers · h-index 29

Impact in

  • Hematology top 0.2%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 62
    • Acute Myeloid Leukemia Research 31
    • Chronic Lymphocytic Leukemia Research 46
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 12

Christopher A. Eide

92 papers receiving 4.0k citations

Christopher A. Eide's Hit Papers

Response and Resistance to BCR-ABL1-Targeted Therapies 2020 · 316 citations
3160+4+8Years since publication100200300

Peers

Christopher A. Eide
Comparison fields: 5 of 94
  • Hematology 2.3k
  • Genetics 1.4k
  • Rheumatology 658
  • Oncology 742
  • Molecular Biology 1.5k
Replace Charles Chuah with:
Charles Chuah Singapore
Markus Warmuth United States
Shu Tamura Japan
Yaping Shou United States
Ilaria Iacobucci Italy
Tetsuzo Tauchi Japan
Taghi Manshouri United States
Marı́a José Calasanz Spain
Artur Słupianek United States
Thomas Kindler Germany
Christopher A. Eide relative to Charles Chuah Singapore Charles Chuah's profile →
Citations per field
00.5×1.5×
Charles Chuah · 1×
Citations per year

Countries citing papers authored by Christopher A. Eide

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Eide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Eide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Eide more than expected).

Fields of papers citing papers by Christopher A. Eide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Eide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Eide. The network helps show where Christopher A. Eide may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher A. Eide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher A. Eide Line = papers co-authored together Christopher A. Eide links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007494
2
OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML
Hit paper breakdown →
2013375
3 2006334
4
Response and Resistance to BCR-ABL1-Targeted Therapies
Hit paper breakdown →
2020316
5 2017184
6 2019170
7 2010144
8 2015133
9 2010112
10 2014110
11 2014106
12 2008105
13 2011101
14 2013100
15 201592
16 201989
17 201180
18 200867
19 200863
20 201656

About Christopher A. Eide

Christopher A. Eide is a scholar working on Hematology, Genetics, Molecular Biology, Rheumatology and Oncology, having authored 101 papers that have together received 4.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (62 papers), Chronic Lymphocytic Leukemia Research (46 papers), Acute Myeloid Leukemia Research (31 papers), Eosinophilic Disorders and Syndromes (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Protein Degradation and Inhibitors (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Quinazolinone synthesis and applications (5 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (1.4k citations), Rheumatology (658 citations), Oncology (742 citations) and Molecular Biology (1.5k citations). Christopher A. Eide has collaborated with scholars based in United States, India and Brazil. Frequent co-authors include Brian Druker, Thomas O’Hare, Michael W. Deininger, Jeffrey Tyner, Theodore P. Braun, Anupriya Agarwal, Stephanie G. Willis, Shannon K. McWeeney, Marc Loriaux and Cristina E. Tognon. Their work appears in journals such as Blood, Cancer Research, Clinical Cancer Research, Leukemia and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact